Literature DB >> 7301232

Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions.

N F Hacker, R S Leuchter, J S Berek, T W Castaldo, L D Lagasse.   

Abstract

One hundred patients underwent radical vulvectomy and bilateral inguinal lymphadenectomy using separate groin incisions. Forty-nine had stage I disease, 37 stage II, and 14 stage III. Corrected actuarial 5-year survival for each stage was 97.4, 86, and 49.2%, respectively. Inguinal lymph nodes were positive in 25% of cases: 10.2% of stage I, 27% of stage II, and 71.4% of stage III cases. Major complications occurred in 21 patients, including major groin breakdown in 14. Thirty patients experienced no acute postoperative morbidity. The mean postoperative hospital stay was 19 days, and mean operative blood loss was 620 ml. No patients developed isolated metastases in either the groin or the inguinal skin bridge, but 2 stage III patients developed simultaneous metastases in the skin bridge and elsewhere. For appropriately selected patients, separate groin incisions for inguinal lymphadenectomy appear to result in lower morbidity than traditional methods, without compromising survival.

Entities:  

Mesh:

Year:  1981        PMID: 7301232

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  34 in total

1.  Groin lymphadenectomy with preservation of femoral fascia: total inguinofemoral node dissection for treatment of vulvar carcinoma.

Authors:  Leonardo Micheletti; Fabrizio Bogliatto; Marco Massobrio
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

2.  Management options for vulvar carcinoma in a low resource setting.

Authors:  Ahizechukwu C Eke; Lilian I Alabi-Isama; Josephat C Akabuike
Journal:  World J Surg Oncol       Date:  2010-11-01       Impact factor: 2.754

Review 3.  Management of lymph nodes in the treatment of vulvar cancer.

Authors:  Toshiaki Saito; Keiji Kato
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

4.  Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer.

Authors:  Ignacio Zapardiel; Myriam Gracia; Javier Díez; Alessandro Buda; Maria C Noya; Pierandrea De Iaco; Pedro Vieira-Baptista; Sara Iacoponi
Journal:  Arch Gynecol Obstet       Date:  2020-10-16       Impact factor: 2.344

Review 5.  Contemporary quality of life issues affecting gynecologic cancer survivors.

Authors:  Jeanne Carter; Richard Penson; Richard Barakat; Lari Wenzel
Journal:  Hematol Oncol Clin North Am       Date:  2011-12-16       Impact factor: 3.722

6.  Cost-effectiveness analysis of sentinel lymph node biopsy in the treatment of early-stage vulvar cancer.

Authors:  Britt K Erickson; Laura M Divine; Charles A Leath; J Michael Straughn
Journal:  Int J Gynecol Cancer       Date:  2014-10       Impact factor: 3.437

Review 7.  Surgical interventions for early squamous cell carcinoma of the vulva.

Authors:  A Ansink; J van der Velden
Journal:  Cochrane Database Syst Rev       Date:  2000

8.  Use of the Sentinel Lymph Node Technique Compared to Complete Inguino-femoral Lymph Node Removal in Patients with Invasive Vulvar Cancer in Germany.

Authors:  F Kramer; H Hertel; P Hillemanns
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-02       Impact factor: 2.915

9.  Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance.

Authors:  Floris P R Verbeek; Quirijn R J G Tummers; Daphne D D Rietbergen; Alexander A W Peters; Boudewijn E Schaafsma; Cornelis J H van de Velde; John V Frangioni; Fijs W B van Leeuwen; Katja N Gaarenstroom; Alexander L Vahrmeijer
Journal:  Int J Gynecol Cancer       Date:  2015-07       Impact factor: 3.437

10.  Psychosexual adjustment after vulvar surgery.

Authors:  B L Andersen; N F Hacker
Journal:  Obstet Gynecol       Date:  1983-10       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.